Evidence map›Paper›PMID 23325274›Full record

Trial reportEuropean journal of gastroenterology & hepatology2013

Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.

Kevin A Hommel, Elizabeth Hente, Michele Herzer, Lisa M Ingerski, Lee A Denson

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in European journal of gastroenterology & hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 7 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 7 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Technologies as support tools for persons with autistic spectrum disorder: a systematic review.International journal of environmental research and public health · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kevin A HommelDivision of Behavioral Medicine and Clinical Psychology, Center for the Promotion of Treatment Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, MLC 7039, Cincinnati, OH 45229-3039, USA. kevin.hommel@cchmc.org
Elizabeth Hente
Michele Herzer
Lisa M Ingerski
Lee A Denson
Children's Mercy Hospital · USCincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Theresa Alenghat · 2007 to 2026
$24.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR026314 · NCRR · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2009 to 2011
$14.3M
Behavioral Treatment of Nonadherence in Pediatric Inflammatory Bowel DiseaseK23DK079037 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI HOMMEL, KEVIN · 2007 to 2011
$618k
NCRR NIH HHS 1UL1RR026314NCRR NIH HHS UL1 RR026314NIDDK NIH HHS K23 DK079037NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

objectiveTo evaluate an individually tailored multicomponent nonadherence treatment protocol using a telehealth delivery approach in adolescents with inflammatory bowel disease.

methodsNine participants, age 13.71±1.35 years, completed a brief treatment online through Skype. Medication nonadherence, severity of disease, and feasibility/acceptability data were obtained.

resultsAdherence increased markedly from 62% at baseline to 91% for mesalamine (δ=0.63), but decreased slightly from 61% at baseline to 53% for 6-mercaptopurine /azathioprine. The telehealth delivery approach resulted in cost savings of $100 in mileage and 4 h of travel time/patient. Treatment session attendance was 100%, and the intervention was rated as acceptable, particularly in terms of treatment convenience.

conclusionIndividually tailored treatment of nonadherence through telehealth delivery is feasible and acceptable. This treatment shows promise for clinical efficacy to improve medication adherence and reduce costs. Large-scale testing is necessary to determine the impact of this intervention on adherence and health outcomes.

Indexed as

AdolescentAnti-Inflammatory Agents, Non-SteroidalAzathioprineBehavior TherapyChildCost of IllnessDelivery of Health CareDrug Therapy, CombinationFeasibility StudiesFemaleHumansImmunosuppressive AgentsInflammatory Bowel DiseasesMaleMedication AdherenceMercaptopurineAnti-Inflammatory Agents, Non-SteroidalAzathioprineImmunosuppressive AgentsMercaptopurineMesalamine

Identifiers

PMID23325274
PMCPMC3703848
OpenAlexW2136775966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.